Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
Switching to Duloxetine Remits Ziprasidone – Edward C. Lauterbach
Switching to Duloxetine Remits Ziprasidone – Edward C. Lauterbach
$
30.00
Switching to Duloxetine Remits Ziprasidone - Edward C. Lauterbach quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
SKU:
pb-42-3-lauterbach
Categories:
Psychopharmacology Bulletin
,
VOL 42 No. 3 Articles
Tags:
agitation
,
antidepressants
,
antipsychotics
,
edward-c-lauterbach
,
florence-t-baralatei
,
medworks-media
,
neurotransmitter-receptors
,
paranoia
,
psychopharmacology-bulletin
Description
Description
Edward C. Lauterbach
COMPLICATED CASE HISTORIES
Switching to
Duloxetine
Remits
Ziprasidone
– Associated Urinary Incontinence and Improves Neuropsychiatric Behavior in Dementia: Possible Relationship of Incontinence to 5HT2 Receptor
Blockade
Edward C. Lauterbach, Florence T. Baralatei
Share On Facebook
Tweet This Product
Pin This Product
Email This Product
Related products
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
$
30.00
Add to cart
Details
Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais
$
30.00
Add to cart
Details
Antipsychotic Induced Symptomatic Hyperprolactinemia
$
30.00
Add to cart
Details
What Mood Symptoms may be most Difficult to Rate?
$
30.00
Add to cart
Details
Page load link
Go to Top
